BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7464813)

  • 21. Amino acid and energy requirements for rat hepatocytes in primary culture.
    Schwarze PE; Solheim AE; Seglen PO
    In Vitro; 1982 Jan; 18(1):43-54. PubMed ID: 6763597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylalanine hydroxylase in liver cells. Correlation of glucagon-stimulated enzyme phosphorylation with expressed activity.
    Fisher MJ; Pogson CI
    Biochem J; 1984 Apr; 219(1):79-85. PubMed ID: 6721866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of lysosomotropic amines on human polymorphonuclear leucocyte function.
    Vandenbroucke-Grauls CM; Thijssen RM; Marcelis JH; Sharma SD; Verhoef J
    Immunology; 1984 Feb; 51(2):319-26. PubMed ID: 6319273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of dimaprit, nordimaprit, methylamine and chloroquine as inhibitors of mitogen-induced lymphocyte activation.
    Dale MM; Ladd R
    Br J Pharmacol; 1984 Sep; 83(1):293-8. PubMed ID: 6237706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transglutaminase and receptor-mediated endocytosis in macrophages and cultured fibroblasts.
    Davies PJ; Murtaugh MP
    Mol Cell Biochem; 1984; 58(1-2):69-77. PubMed ID: 6200758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are the renin-containing granules of juxtaglomerular epithelioid cells modified lysosomes?
    Taugner R; Whalley A; Angermüller S; Bührle CP; Hackenthal E
    Cell Tissue Res; 1985; 239(3):575-87. PubMed ID: 3886148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cleavage of membrane secretory component to soluble secretory component occurs on the cell surface of rat hepatocyte monolayers.
    Musil LS; Baenziger JU
    J Cell Biol; 1987 Jun; 104(6):1725-33. PubMed ID: 3294861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacologic regulation of the functional activity of the lysosomal apparatus of the cell (review of the literature)].
    Nichoga VD; Dunaev VG
    Farmakol Toksikol; 1978; 41(6):730-50. PubMed ID: 31299
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of drug-induced lysosomal disorders of the liver in man and laboratory animals.
    Schneider P; Korolenko TA; Busch U
    Microsc Res Tech; 1997 Feb; 36(4):253-75. PubMed ID: 9140926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular protein degradation and autophagy in isolated pancreatic acini of the rat.
    Telbisz A; Kovacs AL
    Cell Biochem Funct; 2000 Mar; 18(1):29-40. PubMed ID: 10686581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors and pathways of hepatocytic protein degradation.
    Seglen PO; Gordon PB; Grinde B; Solheim A; Kovács AL; Poli A
    Acta Biol Med Ger; 1981; 40(10-11):1587-98. PubMed ID: 7342604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathways of intracellular sequestration and protein degradation in isolated rat hepatocytes.
    Seglen PO; Gordon PB; Tolleshaug H; Høyvik H
    Prog Clin Biol Res; 1985; 180():437-46. PubMed ID: 4034550
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of lysosomotropic amines on protein degradation, migration of nonhistone proteins to the nucleus, and cathepsin D in lymphocytes.
    Polet H
    J Cell Physiol; 1985 Mar; 122(3):415-23. PubMed ID: 2578477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and immunosuppressive activity of lipophilic amino alcohols and diamines.
    Reis EF; Celso OR; Alves LL; Ferreira AP; de Almeida MV
    Chem Biol Drug Des; 2008 Dec; 72(6):596-8. PubMed ID: 19090927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of lysosomotropic monoamines, diamines, amino alcohols, and other amino compounds on protein degradation and protein synthesis in isolated rat hepatocytes.
    Seglen PO; Gordon PB
    Mol Pharmacol; 1980 Nov; 18(3):468-75. PubMed ID: 7464813
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.